Controlling hypertension during the COVID-19 pandemic

How should clinicians navigate clinical uncertainty for patients who are taking angiotensinconverting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs)?

Standing desks could decrease heart disease

Sitting for more than four hours a day could increase an individual’s risk of death from any health issue –…

Quitting smoking improves heart health

Smoking is a well-known cardiovascular risk factor and smoking cessation leads to a reduced risk of cardiovascular events including mortality…

Dealing with early morning BP surges

Cardio-metabolic disorders are the most important cause of mortality and morbidity worldwide. Hypertension, obesity, diabetes, metabolic syndrome and hyperlipidaemia, cause…

Preserving renal function in diabetic patients with AF

More than 40% of atrial fibrillation (AF) patients have diabetes. Chronic kidney disease (CKD), defined as an estimated glomerular filtration…

SAHS provides clarity on new hypertension threshold

In 2017, the publication of the new American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guideline created considerable controversy.…

How to TREAT-AF

Studies show that the prevalence of AF ranges from 1% to 15% in people between the ages of 35 and…

Read More
CPD POINTS: 1

Medical Chronicle August 2019 CPDs

These are both CPDs produced for the August 2019 issue of Medical Chronicle, accredited for 3 points. This month’s CPDs…

Reducing heart failure with hypertension treatment

Worldwide the prevalence of heart failure is rising. Prognosis is poor with symptomatic heart failure with yearly mortality rate of…

Angina: warn patients to listen to their heart

More South Africans die of CVD than of all the cancers combined. A common symptom of CAD is angina, yet…

Simplifying hypertension guidelines

The International Society of Hypertension (ISH) is currently writing new global hypertension guidelines to be published during the first half…

Anticoagulation in non-valvular AF

Atrial fibrillation is the most common persistent cardiac arrhythmia that a practitioner of medicine will encounter in clinical practice and…

CVD risk factors in PD patients

Parkinson’s disease (PD) is the second most common neurodegenerative condition after Alzheimer’s disease. The incidence of PD rises rapidly with…

Down the ABC pathway

Atrial fibrillation (AFib) is the most common arrhythmia diagnosed in clinical practise. However, some patients experience no symptoms. Left untreated,…

Fast facts about Takotsubo

Takotsubo syndrome was first described in early 1990s in Japan as a transient cardiomyopathy after a stressful event in the…

Inflammation, immunity and infection in atherothrombosis

This is a new review topic addressing the overall concept of atherosclerosis and where we are at this moment in…

Updated atrial fibrillation guidelines

There is now a focused Update of the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) Guideline for…

Preventing cardiovascular disease: where to start

Cardiovascular disease affects 33% of adults in the world and as such is the largest epidemic ever known to mankind,…

AFib Better Care

The Mayo Clinic hosted its annual Arrhythmias and the Heart: A Cardiovascular Update in Hawaii (United States) at the end…

Future trends in cardiology

The future of cardiology looks bright, and cardiologists need to be aware of an increased focus on fractional flow reserve-computed…

« » page 1 / 2